The company's own safety disclosure on the GLP-1 page states that compounded GLP-1s "have not been evaluated by the FDA for safety, quality, or efficacy." This is a critical distinction
GHK-Cu has more extensive human clinical research, particularly in dermatological applications
Other patients receive an antibiotic to kill the odor causing bacteria
These usually resolve within a few hours
The present invention relates in a further aspect to a method for isolating a GLP-1 peptide, the method including purification of a GLP-1 peptide from a mixture comprising said peptide and related or unrelated impurities via a cation exchange chromatography process, the cation exchange chromatography process comprising the step of: separating said GLP-1 peptide and said related impurities of said mixture by elution in a solution consisting essentially of an organic modifier, water, optionally a salt component, and optionally a buffer, with a linear or step gradient or isocratically in salt component and/or with a linear or step pH-gradient or at a constant pH-value, wherein the pH-gradient or pH-value should be in the range where said peptide has a positive local or overall net charge different from the local or overall positive net charge of said related impurities so as to remove said related impurities
What happens if I am not approved
